Kaplan Meier estimate

Related by string. Kaplan Meier estimates * Kaplans . KAPLAN : Ari Kaplan . Perrin Kaplan vice . Perrin Kaplan . Kluger Peretz Kaplan / Meis . mei . MEI . MEIER : Sid Meier Civilization IV . Sid Meier Civilization Revolution . Chi Mei Optoelectronics CMO . Sid Meier Civilization / esti mates . ESTIMATES . ESTIMATE : AS ESTIMATE ANTICIPATE BELIEVE . Results Beats Estimates . Reuters Estimates * *

Related by context. Frequent words. (Click for all words.) 66 patients evaluable 65 RECIST criteria 63 Secondary endpoints include 62 evaluable 62 heavily pretreated 62 mg kg dose 61 evaluable patients 61 plus dexamethasone 60 chlorambucil 60 free survival PFS 60 virologic failure 59 prespecified 59 liver transplant recipients 59 peginterferon 58 median PFS 58 % CI #.#-#.# [007] 58 Median survival 58 cytogenetic response 58 decitabine 58 RRMS patients 58 virologic response 58 RECIST 58 mcg dose 58 complete remissions 58 postoperatively 57 virologic 57 CMV disease 57 dose regimens 57 PRECiSE 57 dose cohorts 57 Secondary endpoints included 57 disease progression 57 sustained virologic response 57 topotecan 57 tumor resection 57 dose titration 57 chemoradiotherapy 56 HSCT 56 azacitidine 56 ACR# response 56 mg QD 56 placebo controlled clinical trials 56 seroconversion 56 lipid lowering therapy 56 plus methotrexate 56 annualized relapse 56 XELOX 55 androgen deprivation 55 peginterferon alfa 2a 55 nab paclitaxel 55 ponatinib 55 glycemia 55 plus gemcitabine 55 liver metastases 55 tamoxifen therapy 55 serum uric acid 55 plus prednisone 55 low dose dexamethasone 55 nonadherence 55 noninferiority 55 indolent NHL 55 adalimumab 54 Jevtana 54 glufosfamide 54 distant metastasis 54 Secondary endpoints 54 neoadjuvant 54 Fludara 54 plus ribavirin 54 fibrinolysis 54 romiplostim 54 axitinib 54 undetectable viral load 54 GVAX 54 FOLFOX 54 postsurgical 54 chemoradiation 54 neoadjuvant therapy 54 patients 54 confidence interval #.#-#.# 54 cirrhotic patients 54 placebo controlled clinical 54 gout flares 54 estimated glomerular filtration 54 relapsing MS 54 confidence interval CI 54 IU mL 54 creatinine clearance 54 serum concentrations 54 inhaled nitric oxide 54 therapeutic regimens 54 pharmacodynamic effects 54 multivariate analyzes 54 platelet inhibition 54 abiraterone acetate 54 tumor recurrence 54 COPD exacerbations 54 P = .# 54 Pharmacokinetic 54 sunitinib 53 neoadjuvant chemotherapy

Back to home page